At BioReperia, we’re transforming how cancer therapies are developed and personalized. With over 55 years of world-renowned combined experience in zebrafish tumor models, and 10 years since our company's founding, our team delivers deep scientific expertise through the ZTX® platform – a fast, reliable, and CE-certified in vivo system that provides actionable results in just five days.
Backed by strong validation and trusted by pharma, biotech, and clinicians, ZTX® offers a uniquely powerful, highly predictive, and cost-effective tool that provides high-resolution evaluation of tumor regression, metastasis inhibition, and immune interactions – using cell lines, PDX models, or patient-derived material. Whether you're developing small molecules or biologics, our platform empowers confident, data-driven decisions throughout the drug development pipeline.
ZTX® PREDICT: Match patients with the most effective therapies to drive personalized oncology.
ZTX® ONCOLEADS: Accelerate early discovery and strengthen preclinical programs with rapid, translatable efficacy data.
By bridging human tumor biology with the speed and precision of ZTX® we help reduce R&D attrition, cut timelines, and increase clinical success.
Let’s bring better cancer treatments to patients faster!
Get in touch at info@bioreperia.com | www.bioreperia.com
Company Details
- Employees
- 21
- Founded
- -
- Address
- Westmansgatan, 47,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bioreperia.com
- Keywords
- Oncology, Drug Discovery, Toxicology, Zebrafish, Clinical Trials, PDX models, Precision medicine, Drug development, CDX models, Immunotherapy, Patient stratification, Lead optimization, Target validation, Screening.
- HQ
- Linköping, Ostergotland County
Bioreperia Questions
Bioreperia's website is bioreperia.com
Bioreperia's LinkedIn profile is https://se.linkedin.com/company/bioreperia
Bioreperia has
21 employees.
View email and phone details for 21
employees at Bioreperia.
Bioreperia's industry is
Biotechnology Research
Bioreperia's top competitors are
Scilifelab,
Nordic Biomarker,
Pentagrit Discovery - Zebrafish Cro,
Dynamic Code,
Invenesis,
Celluminova,
Arguseye,
Zeclinics,
Neotargets Ab,
Invivo Biosystems.
Bioreperia's categories are Biotechnology Research
Bioreperia's founding year is 2015
